Skip to content
KN

Knowles Corp

Knowles Corp Q3 FY2024 earnings call

October 24, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$0.26 / $0.26Miss -0.8%

Revenue · actual vs est

$142.5M / $148.7MMiss -4.2%
Ask about this call

Summary

Generated 2024-10-24

Management highlights

  • Signed definitive agreement to sell Consumer MEMS Microphone business to focus on higher growth markets. - Third quarter revenue $143 million (high end of guided range), 32% YOY growth (Cornell + 4% organic), EPS $0.26 (midpoint of guided range), cash from operations $53 million (exceeding guided range). - Medtech & Specialty Audio grew 10% YOY; Apple's AirPod Pro 2 software update expected to drive hearing aid adoption. - Precision Device saw revenue growth from Cornell, margin expansion via cost synergies, pricing, and capacity utilization; expects modest sequential revenue growth in Q4 with healthy pipeline.
View in transcript ↓

Segment performance

In Q3, Medtech & Specialty Audio revenue was $64 million, up 10% year-over-year, representing 44.76% of total revenue ($143 million). Gross margins were 53.1%, down 60 basis points. Precision Device revenue was $79 million, up 57% year-over-year (driven by Cornell acquisition), 6% sequentially. Gross margins were 40%, down 40 basis points, but Cornell's gross margin improved 500 basis points since Q1.

View in transcript ↓

Guidance

  • Fourth quarter 2024 revenues expected $141M - $151M (up 5% YOY). - R&D expenses $8M - $9M, SG&A $23M - $25M. - Adjusted EBIT margin 21% - 23%, EPS $0.26 - $0.30. - Cash from operations $30M - $40M, capital spending $6M.
View in transcript ↓

Risks

  • Inconsistent bookings in industrial end market. - Inventory levels in industrial and distribution partners. - Risks related to demand, trends, and potential material differences from expectations as per SEC filings.
View in transcript ↓

Q&A highlights

Q: Underlying demand in PD, end markets, weakness, recovery?

A: Defense is okay, medtech growing, electrification flattish, industrial weak (North America/Europe), distribution has 6 months inventory, needs to come down 3 months.

Q: CapEx go-forward, M&A environment?

A: CapEx over cycle ~3% of revenue, M&A selective, EBITDA multiple expanding, looking at opportunities.

Q: Cornell margin expansion, pricing, industrial inventory?

A: Pricing to add ~$5M this year, more in 2025; industrial distribution inventory ~6 months, needs to come down 3 months.

Q: Industrial sequential trends, end markets geographically?

A: PD expecting modest sequential growth, defense/medtech up, electrification/industrial flat; industrial in NA/Europe, less in Asia.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.26$0.26-0.8%
Revenue$142.5M$148.7M-4.2%

Transcript

October 24, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.